Los Angeles Capital Management’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-213,294
Closed -$245K 1206
2023
Q2
$245K Sell
213,294
-219,442
-51% -$259K ﹤0.01% 1070
2023
Q1
$459K Sell
432,736
-13,162
-3% -$19K ﹤0.01% 879
2022
Q4
$678K Sell
445,898
-51,292
-10% -$88.2K ﹤0.01% 818
2022
Q3
$1.05M Sell
497,190
-115,511
-19% -$244K 0.01% 677
2022
Q2
$821K Sell
612,701
-16,200
-3% -$24K ﹤0.01% 795
2022
Q1
$1.33M Sell
628,901
-50,171
-7% -$122K 0.01% 660
2021
Q4
$2.52M Buy
679,072
+158,985
+31% +$684K 0.01% 466
2021
Q3
$2.6M Buy
+520,087
New +$2.99M 0.01% 463

Other funds holding PGEN

Los Angeles Capital Management's PGEN Position: Q3 2023 in Review

Los Angeles Capital Management sold out of Precigen (PGEN) in Q3 2023, closing a stake of 213,294 shares — an estimated $245K sold.

Los Angeles Capital Management first reported a position in PGEN in Q3 2021 and held it in 8 quarters. The position peaked at $2.6M in Q3 2021. 138 funds tracked by Wall St. Rank hold PGEN as of Q3 2023.

  • Los Angeles Capital Management reported no remaining Precigen position as of Q3 2023 after selling out during the quarter.
  • Los Angeles Capital Management sold 213,294 Precigen shares in Q3 2023, an estimated $245K.
  • Los Angeles Capital Management first reported a position in Precigen in Q3 2021 and held it in 8 quarters.
  • Los Angeles Capital Management's Precigen position peaked at $2.6M in Q3 2021.
  • 138 funds tracked by Wall St. Rank held Precigen as of Q3 2023.

Based on Los Angeles Capital Management's 13F filing for Q3 2023, filed 6 Nov 2023.